Endogenous melatonin predicts efficacy of exogenous melatonin in consolidation of fragmented wrist-activity rhythm of adult patients with developmental brain disorders: A double-blind, placebo-controlled, crossover study

Sleep Medicine

Volumn 8, Issue 3, 2007, Pages 222-239

  Laakso, Maija Liisa ^a   Lindblom, Niki ^a   Leinonen, Lea ^a   Kaski, Markus ^a  

^a Rinnekoti Foundation Finland   (Finland)

Author keywords

Actigraphy; Circadian rhythms; Melatonin; Mental retardation; Sleep disorders

Indexed keywords

ANTACID AGENT; BACLOFEN; BIPERIDEN; CARBAMAZEPINE; CETIRIZINE; CISAPRIDE; CITALOPRAM; CLOBAZAM; DIAZEPAM; ETIRACETAM; FUROSEMIDE; GLIMEPIRIDE; HALOPERIDOL; HYDROCHLOROTHIAZIDE; LAMOTRIGINE; LEVOMEPROMAZINE; MELATONIN; NITRAZEPAM; NITROFURANTOIN; OMEPRAZOLE; OXAZEPAM; OXCARBAZEPINE; PANTOPRAZOLE; PHENOBARBITAL; PHENYTOIN; PLACEBO; TIZANIDINE; TRIMETHOPRIM; UNINDEXED DRUG; VALPROIC ACID;

ACTIMETRY; ADULT; ARTICLE; BLINDNESS; BRAIN DISEASE; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DAYTIME SOMNOLENCE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG EFFICACY; FATIGUE; FEMALE; HORMONE BLOOD LEVEL; HORMONE RELEASE; HUMAN; MALE; MOTOR DYSFUNCTION; NONPARAMETRIC TEST; POLYSOMNOGRAPHY; PREDICTION; PRIORITY JOURNAL; REGRESSION ANALYSIS; REST; SEIZURE; SLEEP DISORDER; STRUCTURED INTERVIEW; TABLET FORMULATION; TREATMENT DURATION; TREATMENT OUTCOME;

ADULT; CIRCADIAN RHYTHM; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; HUMANS; MALE; MELATONIN; MENTAL RETARDATION; MIDDLE AGED; MOTOR ACTIVITY; POLYSOMNOGRAPHY; SLEEP DISORDERS, CIRCADIAN RHYTHM; TREATMENT OUTCOME;

EID: 33947711309     PISSN: 13899457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sleep.2006.09.006     Document Type: Article

References (58)

1. Dawson D., and Encel N. Melatonin and sleep in humans. J Pineal Res 15 (1993) 1-12
2. Jan J.E., and O'Donnell M.E. Use of melatonin in the treatment of paediatric sleep disorders. J Pineal Res 21 (1996) 193-199
3. Sack R.L., Lewy A.J., and Hughes R.J. Use of melatonin for sleep and circadian rhythm disorders. Ann Med 30 (1998) 115-121
4. Turk J. Melatonin supplementation for severe and intractable sleep disturbance in young people with genetically determined developmental disabilities: short review and commentary. J Med Genet 40 (2003) 793-796
5. Zhdanova I.V. Melatonin as a hypnotic: Pro. Sleep Med Rev 9 (2005) 51-65
6. Phillips L., and Appleton R.E. Systematic review of melatonin treatment in children with neurodevelopmental disabilities and sleep impairment. Dev Med Child Neurol 46 (2004) 771-775
7. Buscemi N, Vandermeer B, Pandya R, et al. Melatonin for treatment of sleep disorders. Evidence Report No. 108, University of Alberta Evidence-based Practice Center, Edmonton, Alberta, Canada; 2004. 137 p. http://www.ahrq.gov/downloads/pub/evidence/pdf/melatonin/melatonin.pdf/.
8. MacMahon K.M.A., Broomfield N.M., and Espie C.A. A systematic review of the effectiveness of oral melatonin for adults (18 to 65 years) with delayed sleep phase syndrome and adults (18 to 65 years) with primary insomnia. Curr Psychiat Rev 1 (2005) 103-113
9. van den Heuvel C.J., Ferguson S.A., Macchi M.M., and Dawson D. Melatonin as a hypnotic: Con. Sleep Med Rev 9 (2005) 71-80
10. McArthur A.J., and Budden S.S. Sleep dysfunction in Rett syndrome: a trial of exogenous melatonin treatment. Dev Med Child Neurol 40 (1998) 186-192
11. O'Callaghan F.J.K., Clarke A.A., Hancock E., Hunt A., and Osborne J.P. Use of melatonin to treat sleep disorders in tuberous sclerosis. Dev Med Child Neurol 41 (1999) 123-126
12. Dodge N.N., and Wilson G.A. Melatonin for treatment of sleep disorders in children with developmental disabilities. J Child Neurol 16 (2001) 581-584
13. Niederhofer H., Staffen W., Mair A., and Pittschieler K. Brief report: melatonin facilitates sleep in individuals with mental retardation and insomnia. J Autism Dev Disord 33 (2003) 469-472
14. Coppola G., Iervolino G., Mastrosimone M., La Torre G., Ruiu F., and Pascotto A. Melatonin in wake-sleep disorders in children, adolescents and young adults with mental retardation with or without epilepsy: a double-blind, crossover, placebo-controlled trial. Brain Dev 26 (2004) 373-376
15. Camfield P., Gordon K., Dooley J., and Camfield C. Melatonin appears ineffective in children with intellectual deficits and fragmented sleep: six "N of 1" trials. J Child Neurol 11 (1996) 341-343
16. Hätönen T., Kirveskari E., Heiskala H., Sainio K., Laakso M.-L., and Santavuori P. Melatonin ineffective in neuronal ceroid-lipofuscinosis patients with fragmented or normal motor activity rhythms recorded by wrist actigraphy. Mol Genet Metab 66 (1999) 401-406
17. Haimov I., Lavie P., Laudon M., Herer P., Vigder C., and Zisapel N. Melatonin replacement therapy of elderly insomniacs. Sleep 18 (1995) 598-603
18. Garfinkel D., Laudon M., and Zisapel N. Improvement of sleep quality by controlled-release melatonin in benzodiazepine-treated elderly insomniacs. Arch Gerontol Geriatr 24 (1997) 223-231
19. Hughes R.J., Sack R.L., and Lewy A.J. The role of melatonin and circadian phase in age-related sleep-maintenance insomnia: assessment in a clinical trial of melatonin replacement. Sleep 21 (1998) 52-68
20. Leger D., Laudon M., and Zisapel N. Nocturnal 6-sulphatoxymelatonin excretion in insomnia and its relation to the response to melatonin replacement therapy. Am J Med 116 (2004) 91-95
21. Partinen M., and Gislason T. Basic Nordic Sleep Questionnaire (BNSQ): a quantitated measure of subjective sleep complaints. J Sleep Res 4 (1995) 150-155
22. Laakso M.-L., Leinonen L., Lindblom N., Joutsiniemi S.-L., and Kaski M. Wrist actigraphy in estimation of sleep and wake in intellectually disabled subjects with motor handicaps. Sleep Med 5 (2004) 541-550
23. 125I-radioimmunoassay without extraction. In: Gupta D., Wollman H.A., and Ranke M.B. (Eds). Neuroendocrinology: new frontiers (1990), Brain Research Promotion, Tübingen, London 255-264
24. Carskadon M.A., and Rechtschaffen A. Monitoring and staging human sleep. In: Kryger M.H., Roth T., and Dement W.C. (Eds). Principles and practice of sleep medicine. 3rd ed. (2000), Saunders, Philadelphia 1197-1215
25. Van Someren E.J.W., Swaab D.F., Colenda C.C., Cohen W., McCall W.V., and Rosenquist P.B. Bright light therapy: Improved sensitivity to its effects on rest-activity rhythms in Alzheimer patients by application of nonparametric methods. Chronobiol Int 16 (1999) 505-518
26. Hedeker D., and Gibbons R.D. MIXREG: a computer program for mixed-effects regression analysis with autocorrelated errors. Comp Meth Progr Biomed 49 (1996) 229-252
27. Snijders T.A.B., and Bosker R.J. Multilevel Analysis. An introduction to basic and advanced multilevel modeling (1999), Sage, London p. 88-90
28. Laakso M.-L., Lindblom N., Kaipainen P., and Kaski M. Urinary 6-hydroxymelatonin sulfate excretion in intellectually disabled subjects with sleep disorders and multiple medications: validation of measurements in urine extracted from diapers. Scand J Clin Lab Invest 65 (2005) 413-432
29. Laakso M.-L., Leinonen L., Hätönen T., Alila A., and Heiskala H. Melatonin, cortisol and body temperature rhythms in Lennox-Gastaut patients with or without circadian rhythm sleep disorders. J Neurol 240 (1993) 410-416
30. Tamarkin L., Abastillas P., Chen H.-C., McNemar A., and Sidbury J.B. The daily profile of plasma melatonin in obese and Prader-Willi syndrome children. J Clin Endocrinol Metab 55 (1982) 491-495
31. Willig R.P., Braun W., Commentz J.C., and Stahnke N. Circadian fluctuation of plasma melatonin in Prader-Willi's syndrome and obesity. Acta Endocrinol (Copenh) Suppl. 279 (1986) 411-415
32. Reiter R.J., Barlow-Walden L., Poeggeler B., Heiden S.M., and Clayton R.J. Twenty-four hour urinary excretion of 6-hydroxymelatonin sulfate in Down syndrome subjects. J Pineal Res 20 (1996) 45-50
33. Heikkilä E., Hätönen T.H., Telakivi T., et al. Circadian rhythm studies in neuronal ceroid-lipofuscinosis (NCL). Am J Med Genet 57 (1995) 229-234
34. Hätönen T., Laakso M.-L., Heiskala H., Alila A., Sainio K., and Santavuori P. Bright light suppresses melatonin in blind patients with neuronal ceroid-lipofuscinoses (NCL). Neurology 50 (1998) 1445-1450
35. Gould E.L., Loesch D.Z., Martin M.J., Hagerman R.J., Armstrong S.M., and Huggins R.M. Melatonin profiles and sleep characteristics in boys with fragile X syndrome: a preliminary study. Am J Med Genet 95 (2000) 307-315
36. O'Hare J.P., O'Brien I.A.D., Arendt J., et al. Does melatonin deficiency cause the enlarged genitalia of the fragile-X syndrome?. Clin Endocrinol 24 (1986) 327-333
37. Miyamoto A., Oki J., Takahashi S., and Okuno A. Serum melatonin kinetics and long-term melatonin treatment for sleep disorders in Rett syndrome. Brain Dev 21 (1999) 59-62
38. Yamashita Y., Matsuishi T., Murakami Y., and Kato H. Sleep disorder in Rett syndrome and melatonin treatment. Brain Dev 21 (1999) 570
39. Zhdanova I.V., Wurtman R.J., and Wagstaff J. Effects of a low dose of melatonin on sleep in children with Angelman syndrome. J Pediatr Endocrinol Metab 12 (1999) 57-67
40. Potocki L., Glaze D., Tan D.-X., et al. Circadian rhythm abnormalities of melatonin in Smith-Magenis syndrome. J Med Genet 37 (2000) 428-433
41. De Leersnyder H., de Blois M.-C., Claustrat B., et al. Inversion of the circadian rhythm of melatonin in the Smith-Magenis syndrome. J Pediatr 139 (2001) 111-116
42. Shibui K., Uchiyama M., and Okawa M. Melatonin rhythms in delayed sleep phase syndrome. J Biol Rhythms 14 (1999) 72-76
43. Skene D.J., Lockley S.W., and Arendt J. Melatonin in circadian sleep disorders in the blind. Biol Signals Recept 8 (1999) 90-95
44. Haimov I., Laudon M., Zisapel N., et al. Sleep disorders and melatonin rhythms in elderly people. Br Med J 309 (1994) 167
45. Hajak G., Rodenbeck A., Staedt J., Bandelow B., Huether G., and Rüther E. Nocturnal plasma melatonin levels in patients suffering from chronic primary insomnia. J Pineal Res 19 (1995) 116-122
46. Shilo L., Dagan Y., Smorjik Y., et al. Patients in the intensive care unit suffer from severe lack of sleep associated with loss of normal melatonin secretion pattern. Am J Med Sci 317 (1999) 278-281
47. Riemann D., Klein T., Rodenbeck A., et al. Nocturnal cortisol and melatonin secretion in primary insomnia. Psychiatry Res 113 (2002) 17-27
48. Youngstedt S.D., Kripke D.F., and Elliott J.A. Melatonin excretion is not related to sleep in the elderly. J Pineal Res 24 (1998) 142-145
49. Lushington K., Dawson D., Kennaway D.J., and Lack L. The relationship between 6-sulphatoxymelatonin and polysomnographic sleep in good sleeping controls and wake maintenance insomniacs, aged 55-80 years. J Sleep Res 8 (1999) 57-64
50. Zhdanova I.V., Wurtman R.J., Regan M.M., Taylor J.A., Shi J.P., and Leclair O.U. Melatonin treatment for age-related insomnia. J Clin Endocrinol Metab 86 (2001) 4727-4730
51. Monti J.M., Alvarino F., Cardinali D., Savio I., and Pintos A. Polysomnographic study of the effect of melatonin on sleep in elderly patients with chronic primary insomnia. Arch Gerontol Geriatr 28 (1999) 85-98
52. Baskett J.J., Broad J.B., Wood P.C., Duncan J.R., Pledger M.J., English J., and Arendt J. Does melatonin improve sleep in older people? A randomised crossover trial. Age Ageing 32 (2003) 164-170
53. Van der Heijden K.B., Smits M.G., Van Someren E.J.W., and Boudewijn G.W. Prediction of melatonin efficacy by pretreatment dim light melatonin onset in children with idiopathic chronic sleep onset insomnia. J Sleep Res 14 (2005) 187-194
54. Arendt J. Does melatonin improve sleep? Efficacy of melatonin (letter). Br Med J 332 (2006) 550
55. 7 melatonin. Biopharm Drug Dispos 21 (2000) 15-22
56. Lindblom N., Heiskala H., Kaski M., Leinonen L., and Laakso M.-L. Sleep fragmentation in mentally retarded people decreases with increasing daylength in spring. Chronobiol Int 19 (2002) 1-19
57. Van Someren E.J.W., Hagebeuk E.E., Lijzenga C., Scheltens P., de Rooij S.E., Jonker C., et al. Circadian rest-activity rhythm disturbances in Alzheimer's disease. Biol Psychiatry 40 (1996) 257-270
58. Van Someren E.J.W., Kessler A., Mirmiran M., and Swaab D.F. Indirect bright light improves circadian rest-activity rhythm disturbances in demented patients. Biol Psychiatry 41 (1997) 955-963